Schedule of Operating and Reportable Segments |
The tables below summarize information about our reportable segments. | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Total segment revenues* | 212,578 | | | $ | 36,952 | | | | | $ | 249,530 | | Cost of sales | 92,178 | | | 17,021 | | | | | 109,199 | | Gross profit | 120,400 | | | 19,931 | | | | | 140,331 | | Advertising and marketing | 28,954 | | | 5,983 | | | | | 34,937 | | Contribution margin | $ | 91,446 | | | $ | 13,948 | | | | | $ | 105,394 | | Other operating expenses | | | | | | | 33,638 | | Operating income | | | | | | | $ | 71,756 | | * Intersegment revenues of $0.6 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Total segment revenues* | $ | 232,316 | | | $ | 34,826 | | | | | $ | 267,142 | | Cost of sales | 105,559 | | | 15,561 | | | | | 121,120 | | Gross profit | 126,757 | | | 19,265 | | | | | 146,022 | | Advertising and marketing | 33,753 | | | 5,612 | | | | | 39,365 | | Contribution margin | $ | 93,004 | | | $ | 13,653 | | | | | $ | 106,657 | | Other operating expenses | | | | | | | 34,611 | | Operating income | | | | | | | $ | 72,046 | | * Intersegment revenues of $0.7 million were eliminated from the North American OTC Healthcare segment. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
Schedule of Revenues from Similar Product Groups |
The tables below summarize information about our segment revenues from similar product groups. | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2025 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Analgesics | $ | 27,258 | | | $ | 1,674 | | | | | $ | 28,932 | | Cough & Cold | 13,353 | | | 5,654 | | | | | 19,007 | | Women's Health | 51,646 | | | 5,112 | | | | | 56,758 | | Gastrointestinal | 43,696 | | | 14,088 | | | | | 57,784 | | Eye & Ear Care | 27,781 | | | 4,527 | | | | | 32,308 | | Dermatologicals | 27,852 | | | 2,257 | | | | | 30,109 | | Oral Care | 18,154 | | | 3,548 | | | | | 21,702 | | Other OTC | 2,838 | | | 92 | | | | | 2,930 | | | | | | | | | | Total segment revenues | $ | 212,578 | | | $ | 36,952 | | | | | $ | 249,530 | |
| | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, 2024 | (In thousands) | North American OTC Healthcare | | International OTC Healthcare | | | | Consolidated | Analgesics | $ | 27,011 | | | $ | 1,282 | | | | | $ | 28,293 | | Cough & Cold | 14,961 | | | 5,736 | | | | | 20,697 | | Women's Health | 50,495 | | | 4,083 | | | | | 54,578 | | Gastrointestinal | 44,287 | | | 13,728 | | | | | 58,015 | | Eye & Ear Care | 43,319 | | | 4,811 | | | | | 48,130 | | Dermatologicals | 31,603 | | | 1,752 | | | | | 33,355 | | Oral Care | 17,674 | | | 3,100 | | | | | 20,774 | | Other OTC | 2,966 | | | 334 | | | | | 3,300 | | | | | | | | | | Total segment revenues | $ | 232,316 | | | $ | 34,826 | | | | | $ | 267,142 | |
|